FDA's Sharfstein bemoans speed of regulatory initiatives; India wants cold chain culture;

> "I keep a list of things that I wish were moving faster and a list of things moving at just the right speed, and there's nothing on the second list."--FDA Deputy Commissioner Joshua Sharfstein. Article

> India's Pharmaceuticals Export Promotion Council will study warehousing conditions at sea ports, an early step in its effort to create a cold chain culture. Report

> Start-up BioLOGIS aims to be a one-stop vendor for cargo security, shipment tracking and biometric condition monitoring. Story

> Pfizer is spending $42 million to build a facility at its biotech packaging and distribution site in Havant, UK. Article

> Almac's tech business unit has joined the analytical testing and clinical supplies units in occupying the company's just-completed North American headquarters in Souderton, PA. Almac release

> Becton, Dickinson and Co. has opened the GMP-compliant biosciences advanced bioprocessing production facility in Miami. News

> Pharmetics is pulling up stakes in Niagra, imperiling 200 manufacturing jobs. Article

> Nigerian drugmakers were skipped over for the proposed Affordable Medicine for Malaria project because none were considered competent. Story

> Biovet, a subsidiary of Huvepharma, is building a biopharma plant in Razgrad, Bulgaria. Item

> Bormioli Rocco Glass has unveiled the Delta lightweight glass vials for injectables, intended to replace tubular glass vials. Bormioli release

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.